apoptosis inhibitors (Elan)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameapoptosis inhibitors (Elan)
Drug Alias Nameapoptosis inhibitors (The Liposome Company)ceramide derivatives (The Liposome Company)N-hexylsphinganinesphingosine derivatives (The Liposome Company)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Liposome Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Liposome Company IncElan Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A